"Covance by Labcorp, a global contract research organization (CRO), is the world’s most comprehensive drug development company."

During the past decade, Covance Central Laboratory Services,Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Covance Central Laboratory Services,Inc" are "Ankylosing Spondylitis" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Covance Central Laboratory Services,Inc" in a lesser frequency.

Most popular intervention types in "Covance Central Laboratory Services,Inc" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "PF-00547659 SC Injection" (1 trials), "Tofacitinib 10 mg" (1 trials), "Tofacitinib 2 mg" (1 trials) and "Tofacitinib 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Covance Central Laboratory Services,Inc" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Covance Central Laboratory Services,Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Covance Central Laboratory Services,Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Covance Central Laboratory Services,Inc, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".